Tag: Amniotic Membrane
From Optometry Student to Ophthalogix Canada CEO: Dr. Julian Prosia’s Journey
Dr. Julian Prosia is helping shape the future of dry eye innovation through advanced amniotic membrane technology, biologic therapies, and modern ocular surface disease management. In this conversation, the CEO of Ophthalogix Canada discusses the evolution of amniotic membrane treatment, emerging dry eye trends, IPL advancements, neurotrophic keratitis management, and the mindset required to become a leader in modern eye care.